Ron Johnson said...
Members of Congress beat up on the FDA, and so, they become even more risk averse.
Context
Congressional criticism makes the FDA more cautious in drug approvals.
02/24/2016
Congressional criticism makes the FDA more cautious in drug approvals.
02/24/2016